Marvell earns a Buy rating due to its relative valuation advantage and strategic positioning within AI data center infrastructure. MRVL's growth is driven by high data center revenue concentration and ...
January 5 - Added a note on hotfix 15, which reverts the controversial change to room locks in the Vaal Temple. New Path of Exile 2 patch notes have just dropped from developer Grinding Gear Games ...
As more AI workloads are scaled into energy-intensive data centers, the pressure on power supply chains will intensify. Lenovo's Simone Larsson told CNBC there's going to be a "tipping point" where ...
Extending PATH train service to Newark Airport will be delayed for at least 10 years after it was left out of the new capital plan to cover higher costs to replace the aging airport monorail system.
A nurse who worked at UNC Rex and faces charges of sexual assault was ordered to undergo testing for sexually transmitted diseases. Brayan Alvarez-Ortiz, 28, was arrested Dec. 10 on allegations he ...
"There were some special factors of practical factors that really are related to the fact that they weren't able to collect data in October and not in the first half of November," Williams said. "And ...
Local fights against new data centers are gaining bipartisan support across the US. Local fights against new data centers are gaining bipartisan support across the US. is a senior science reporter ...
The Deciphering the Data quest in Arc Raiders sends you to Spaceport to check out some Magnetic Decryptors, and finding exactly where they're located can be a bit of a challenge. However, you've come ...
WASHINGTON - U.S. Sen. Jon Husted of Ohio joined three Republican colleagues in urging the Treasury Department to investigate a Chinese company’s acquisition of Epic, a widely used children’s reading ...
GameSpot may get a commission from retail offers. Path of Exile 2 players won't have to wait long for the next update. The Last of the Druids is arriving on December 12, and it's putting more than ...
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...